Updated Drug Development Scrip Report Responds to the Pharma Industry's Maj...(ition of the Report was published in 200...)

Date:10/8/2007

ition of the Report was published in 2003, the impact of sequencing the human genome was just being felt throughout the industry. Now, in 2007, it is apparent that while providing promise for the future, there will be no 'quick fix' for the industry and it must pursue an ever wider range of opportunities to achieve its goals. The result is a networked industry without historical parallel.

Scrip Reports publishes an extensive range of pharmaceutical therapeutic market reports, detailed analyses of the pharmaceutical market for specific geographic areas, in-depth profiles of companies operating in the industry, financial and statistical analyses, directories and other strategic reports on the healthcare sector.

Visit http://www.scripreports.com.

For further press details contact

Jenefer Trevena

Managing Editor

Scrip Publishing

Tel: +44-(0)20-7017-6989

Email: jenefer.trevena@informa.com.

To purchase How Drugs are Developed 2007, contact:

Andrew Maitland

Sales Manager

Tel: +44-(0)20-7017-6859

Email: andrew.maitland@informa.com

quote code JR20004P.

'/>"/>

SOURCE Scrip Reports Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related biology technology :

1. Merge unveils updated medical imaging software
2. Dane County mapping software updated, available to public
3. Lands End Debuts Updated Virtual Model
4. The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis
5. Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins
6. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
7. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
8. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
9. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
10. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
11. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System